Nath Bio-Genes (India) Limited (NATHBIOGEN) - Total Liabilities

Latest as of March 2026: Rs4.17 Billion INR ≈ $45.09 Million USD

Based on the latest financial reports, Nath Bio-Genes (India) Limited (NATHBIOGEN) has total liabilities worth Rs4.17 Billion INR (≈ $45.09 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Nath Bio-Genes (India) Limited - Total Liabilities Trend (2012–2026)

This chart illustrates how Nath Bio-Genes (India) Limited's total liabilities have evolved over time, based on quarterly financial data. See Nath Bio-Genes (India) Limited current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Nath Bio-Genes (India) Limited Competitors by Total Liabilities

The table below lists competitors of Nath Bio-Genes (India) Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Q linea AB ST:QLINEA	Sweden	Skr29.06 Million
Hammer Metals Ltd AU:HMX	Australia	AU$1.10 Million
SJM Co Ltd KO:123700	Korea	₩55.39 Billion
Corentec Co Ltd KQ:104540	Korea	₩90.03 Billion
RS GROUP PLC LSE:RS1	UK	GBX1.27 Billion
Wiseway Group Ltd AU:WWG	Australia	AU$64.78 Million
Rossmax International Ltd TWO:4121	Taiwan	NT$2.22 Billion
WINSON Machinery Co Ltd TWO:4538	Taiwan	NT$67.08 Million

Liability Composition Analysis (2012–2026)

This chart breaks down Nath Bio-Genes (India) Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NATHBIOGEN market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.97	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.61	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.38	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nath Bio-Genes (India) Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nath Bio-Genes (India) Limited (2012–2026)

The table below shows the annual total liabilities of Nath Bio-Genes (India) Limited from 2012 to 2026.

Year	Total Liabilities	Change
2026-03-31	Rs4.17 Billion ≈ $45.09 Million	+9.20%
2025-03-31	Rs3.82 Billion ≈ $41.29 Million	+41.25%
2024-03-31	Rs2.70 Billion ≈ $29.23 Million	+23.08%
2023-03-31	Rs2.20 Billion ≈ $23.75 Million	+9.85%
2022-03-31	Rs2.00 Billion ≈ $21.62 Million	+13.45%
2021-03-31	Rs1.76 Billion ≈ $19.06 Million	+2.26%
2020-03-31	Rs1.72 Billion ≈ $18.64 Million	+24.44%
2019-03-31	Rs1.38 Billion ≈ $14.98 Million	+35.80%
2018-03-31	Rs1.02 Billion ≈ $11.03 Million	-32.81%
2017-03-31	Rs1.52 Billion ≈ $16.41 Million	+4.38%
2016-03-31	Rs1.45 Billion ≈ $15.72 Million	+22.17%
2015-03-31	Rs1.19 Billion ≈ $12.87 Million	+10.04%
2014-03-31	Rs1.08 Billion ≈ $11.70 Million	+7.28%
2013-03-31	Rs1.01 Billion ≈ $10.90 Million	+35.81%
2012-03-31	Rs742.27 Million ≈ $8.03 Million	--

About Nath Bio-Genes (India) Limited

NSE:NATHBIOGEN India Agricultural Inputs

Market Cap

$35.35 Million

Rs3.27 Billion INR

Market Cap Rank

#23246 Global

#1287 in India

Share Price

Rs172.01

Change (1 day)

+2.80%

52-Week Range

Rs129.02 - Rs234.84

All Time High

Rs537.81